Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 5:01 PM UTC
| NCT Number | NCT06311682 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE3 |
| Target Enrollment | 195 participants |
| Active Locations | 15 sites in the US |
| Sponsor | LEO Pharma |
| Last Updated on CT.gov | July 7, 2026 (Jul 7, 2026) |
As of September 1, 2026: Clinical trial NCT06311682 is currently recruiting participants. This phase3 study for atopic dermatitis is actively seeking new participants at 15 locations across the United States. The study is sponsored by LEO Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06311682 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06311682 was last updated Jul 7, 2026 (July 7, 2026). HelloStudys verifies this status automatically.